Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Full-text index only
CLK1 Promotes Myeloid-Derived Suppressor Cell Trafficking and Reprograms the Tumor Microenvironment by Activating Hippo/YAP Signaling in Colorectal Cancer.
PMID 41686262 · PMC13136879 · Cancer immunology research · 2026 · 8 claims · 8 setups
CLK1 is markedly upregulated in immune-cold colorectal tumors and correlates with increased MDSC infiltration and CD8+ T-cell exclusion
-
Has reproduction · 37
Orthogonal cytokine engineering enables novel synthetic effector states escaping canonical exhaustion in tumor-rejecting CD8(+) T cells.
PMID 37081150 · PMC10154250 · Nature immunology · 2023 · 8 claims · 7 setups
Orthogonal engineering with PD1d/IL-2v/IL-33 reprograms adoptively transferred CD8+ T cells into a novel synthetic effector state (C5/TSE) that deviates from canonical TOX+ exhaustion
-
Full-text index only
Protocol to annotate dendritic cell maturation types in vivo making use of lipid nanoparticle-based approaches.
PMID 41811845 · PMC12994025 · STAR protocols · 2026 · 8 claims · 8 setups
Different LNP formulations (cargo type, adjuvant presence) can be used to steer DC maturation along a homeostatic-immunogenic spectrum in vivo
-
Full-text index only
Amelioration of colorectal cancer-associated fibroblasts in immunosuppressive microenvironment by ferroptosis-based nanotherapy.
PMID 41690961 · PMC13018587 · Nature communications · 2026 · 8 claims · 8 setups
CAFs drive tumor-promoting activity and immunosuppression, contributing to CRC immunotherapy resistance
-
Full-text index only
A pan-cancer single cell landscape reveals heterogeneity and functional diversity of double-negative T cells.
PMID 41484771 · PMC12882460 · Molecular cancer · 2026 · 7 claims · 5 setups
Integration of pan-cancer scRNA-seq data yields a comprehensive single-cell atlas of 157,025 high-quality DNT cells across 23 cancer types.